Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2002;22:638-643
Published online before print February 14, 2002, doi: 10.1161/01.ATV.0000013023.11297.B2
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
22/4/638    most recent
01.ATV.0000013023.11297.B2v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fournier, N.
Right arrow Articles by Kalopissis, A.-D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fournier, N.
Right arrow Articles by Kalopissis, A.-D.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CHOLESTEROL
Medline Plus Health Information
*Triglycerides
Related Collections
Right arrow Lipid and lipoprotein metabolism
Right arrow Genetically altered mice
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2002;22:638.)
© 2002 American Heart Association, Inc.


Atherosclerosis and Lipoproteins

Opposite Effects of Plasma From Human Apolipoprotein A-II Transgenic Mice on Cholesterol Efflux From J774 Macrophages and Fu5AH Hepatoma Cells

Natalie Fournier; Anne Cogny; Véronique Atger; Danièle Pastier; Dominique Goudouneche; Antonino Nicoletti; Nicole Moatti; Jean Chambaz; Jean-Louis Paul; Athina-Despina Kalopissis

From the Laboratoire de Biochimie (N.F., D.G., N.M., J.-L.P.), Faculté des Sciences Pharmaceutiques, Châtenay-Malabry; Laboratoire de Biochimie (N.F., A.C., V.A., N.M., J.-L.P.), Hôpital Européen Georges Pompidou, AP-HP, Paris; U505 INSERM (D.P., J.C., A.-D.K.), Université Pierre et Marie Curie, Centre de Recherche des Cordeliers, Paris; and U430 INSERM (A.N.), Hôpital Broussais, AP-HP, Paris, France.

Correspondence to Dr N. Fournier, Laboratoire de Biochimie, Faculté des Sciences Pharmaceutiques, 5 rue JB Clément, 92296 Châtenay-Malabry, France. E-mail natalie_fournier{at}yahoo.fr

Overexpression of human apolipoprotein A-II (hapo A-II) in transgenic mice (hAIItg mice) induced marked hypertriglyceridemia and low levels of plasma high density lipoprotein (HDL) with a high hapo A-II content. We sought to determine whether cholesterol efflux to plasma and HDL from these mice would be affected. In the Fu5AH cell system, plasma from hAIItg mice induced a markedly lower cholesterol efflux than did control plasma, in accordance with the dependence of efflux on HDL concentration. Moreover, HDLs from hAIItg mice were less effective acceptors than were control HDLs. In the J774 macrophage cell system, pretreatment with cAMP, which upregulates ATP binding cassette transporter 1, induced a marked increase in the efflux to hAIItg plasma as well as to purified hapo A-I and hapo A-II, whereas it had no effect on cholesterol efflux to control plasma. A strong positive correlation was established between percent cAMP stimulation of efflux and plasma hapo A-II concentration. The cAMP stimulation of efflux to hAIItg mouse plasma may be linked to the presence of pre-ß migrating HDL containing hapo A-II. Thus, despite lower HDL and apolipoprotein A-I contents, the increased ability of plasma from hAIItg mice to extract cholesterol from macrophage-like cells may have an antiatherogenic influence.


Key Words: human apolipoprotein A-II transgenic mice • Fu5AH rat hepatoma cells • J774 mouse macrophages • cholesterol efflux • ATP binding cassette transporter 1




This article has been cited by other articles:


Home page
J. Lipid Res.Home page
G. D. Wool, C. A. Reardon, and G. S. Getz
Apolipoprotein A-I mimetic peptide helix number and helix linker influence potentially anti-atherogenic properties
J. Lipid Res., June 1, 2008; 49(6): 1268 - 1283.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
M. P. Adorni, F. Zimetti, J. T. Billheimer, N. Wang, D. J. Rader, M. C. Phillips, and G. H. Rothblat
The roles of different pathways in the release of cholesterol from macrophages
J. Lipid Res., November 1, 2007; 48(11): 2453 - 2462.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
F. Zimetti, G. K. Weibel, M. Duong, and G. H. Rothblat
Measurement of cholesterol bidirectional flux between cells and lipoproteins
J. Lipid Res., March 1, 2006; 47(3): 605 - 613.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
N. Rotllan, V. Ribas, L. Calpe-Berdiel, J. M. Martin-Campos, F. Blanco-Vaca, and J. C. Escola-Gil
Overexpression of Human Apolipoprotein A-II in Transgenic Mice Does Not Impair Macrophage-Specific Reverse Cholesterol Transport In Vivo
Arterioscler. Thromb. Vasc. Biol., September 1, 2005; 25(9): e128 - e132.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
J. W. J. Beulens, A. Sierksma, A. van Tol, N. Fournier, T. van Gent, J-L. Paul, and H. F. J. Hendriks
Moderate alcohol consumption increases cholesterol efflux mediated by ABCA1
J. Lipid Res., September 1, 2004; 45(9): 1716 - 1723.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
D. Sauvaget, V. Chauffeton, S. Dugue-Pujol, A.-D. Kalopissis, I. Guillet-Deniau, F. Foufelle, J. Chambaz, A. Leturque, P. Cardot, and A. Ribeiro
In Vitro Transcriptional Induction of the Human Apolipoprotein A-II Gene by Glucose
Diabetes, March 1, 2004; 53(3): 672 - 678.
[Abstract] [Full Text] [PDF]